New Developments in Intracanal Medicaments: A Critical Apprisal
RGUHS Journal of Dental Sciences · 2013 · 5 (1)
DOI: 10.26463/rjds.5_1_15 ↗Kurz gefasst
Fachartikel in der Zeitschrift RGUHS Journal of Dental Sciences, 2013. Verfasst von L.Krishna Prasada und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The micro organisms have been implicated in the pathogenesis and progression of pulp and periapical diseases. The primary objective of endodontic treatment is to remove as many bacteria as possible from the root canal system and then to create an environment in which any remaining organisms cannot survive .This can only be achieved through the use of a combination of aseptic treatment techniques chemo mechanical preparation of the root canal antimicrobial irrigating solution and intracanal medicaments. The choice of which intracanal medicament to use is dependent on having an accurate diagnosis of the condition being treated as well as a thorough knowledge of the type of organism likely to be involved and their mechanisms of growth and survival. Many medicaments have been used in an attempt to achieve the above aims but no single preparation has been formed to be completely predictable or effective. The aim of this paper is to focus on recent concepts in use of medicaments during endodontic treatment.nbsp
Zitieren
APA
Prasada, L., J, P., Jose, S., & Kumar, V. (2013). New Developments in Intracanal Medicaments: A Critical Apprisal. RGUHS Journal of Dental Sciences, 5(1). https://doi.org/10.26463/rjds.5_1_15
Vancouver
Prasada L, J P, Jose S, Kumar V. New Developments in Intracanal Medicaments: A Critical Apprisal. RGUHS Journal of Dental Sciences. 2013;5(1). doi:10.26463/rjds.5_1_15
BibTeX
@article{Prasada2013,
author = {Prasada, L.Krishna and J, Pramod and Jose, Sunil and Kumar, Vijay},
title = {New Developments in Intracanal Medicaments: A Critical Apprisal},
journal = {RGUHS Journal of Dental Sciences},
year = {2013},
volume = {5},
number = {1},
doi = {10.26463/rjds.5_1_15}
}
EUVIMED